Upadhyaya Nabin, Karki Surendra, Rana Sujan, Elsohaby Ibrahim, Tiwari Ramanandan, Oli Manoj, Paudel Surya
Veterinary Standards and Drug Regulatory Laboratory, Budhanilakantha, Kathmandu 44600, Nepal.
Food and Agriculture Organization of the United Nations, Emergency Center for Transboundary Animal Diseases, Lalitpur 44700, Nepal.
Animals (Basel). 2023 Apr 17;13(8):1377. doi: 10.3390/ani13081377.
Antimicrobial resistance is a global public health problem and is primarily driven by the widespread overuse of antibiotics. However, antimicrobial use data in animals are not readily available due to the absence of a national database in many developing countries, including Nepal. This study was conducted to estimate the quantities of antimicrobials available in Nepal as an indicator of their use in food-producing animals between 2018 and 2020. Data were collected through surveys targeting major stakeholders: (i) the Department of Drug Administration (DDA), the Government of Nepal (GoN) for the authorized antimicrobials for veterinary use in Nepal, (ii) veterinary pharmaceuticals for antimicrobials produced in Nepal, (iii) the DDA and Veterinary Importers Association for antimicrobials bought by veterinary drug importers, and (iv) the Department of Customs, GoN, for antibiotics sourced through customs. Data showed that in the 3 years, a total of 96 trade names, comprising 35 genera of antibiotics representing 10 classes, were either produced or imported in Nepal. In total, 91,088 kg, 47,694 kg, and 45,671 kg of active ingredients of antimicrobials were available in 2018, 2019, and 2020, respectively. None of the antibiotics were intended for growth promotion, but were primarily for therapeutic purposes. Oxytetracycline, tilmicosin, and sulfadimidine were among the most-used antibiotics in Nepal in 2020. Oxytetracycline was primarily intended for parenteral application, whereas tilmicosin was solely for oral use. Sulfadimidine was available for oral use, except for a small proportion for injection purposes. Aminoglycosides, fluroquinolones, nitrofurans, sulfonamides, and tetracyclines were mostly produced locally, whereas cephalosporins, macrolides and "other" classes of antimicrobials were imported. Amphenicols and penicillins were exclusively imported and nitrofurans were produced locally only. In general, except for tetracyclines, the volume of antimicrobials produced locally and/or imported in 2020 was lower than that in 2018, which corresponded to a decreasing trend in total antimicrobials available. Furthermore, the subsequent years have seen a decrease in the use of critically important antibiotics, particularly class I antibiotics. Finally, this study has firstly established a benchmark for future monitoring of antimicrobial usage in food-producing animals in Nepal. These data are useful for risk analysis, planning, interpreting resistance surveillance data, and evaluating the effectiveness of prudent use, efforts, and mitigation strategies.
抗菌药物耐药性是一个全球性的公共卫生问题,主要是由抗生素的广泛过度使用所驱动。然而,由于包括尼泊尔在内的许多发展中国家没有国家数据库,动物抗菌药物使用数据难以获取。本研究旨在估算2018年至2020年期间尼泊尔可获得的抗菌药物数量,以此作为其在食用动物中使用情况的一个指标。数据通过针对主要利益相关者的调查收集:(i)尼泊尔政府药品管理局(DDA),获取尼泊尔兽医使用的授权抗菌药物;(ii)尼泊尔生产抗菌药物的兽药公司;(iii)DDA和兽药进口商协会,获取兽药进口商购买的抗菌药物;(iv)尼泊尔政府海关部门,获取通过海关进口的抗生素。数据显示,在这三年中,尼泊尔共生产或进口了96个商品名的抗菌药物,包括代表10类的35属抗生素。2018年、2019年和2020年分别有91,088千克、47,694千克和45,671千克抗菌药物活性成分。所有抗生素均非用于促生长,主要用于治疗目的。土霉素、替米考星和磺胺二甲嘧啶是2020年尼泊尔使用最多的抗生素。土霉素主要用于非肠道给药,而替米考星仅用于口服。磺胺二甲嘧啶除少量用于注射外,均可口服。氨基糖苷类、氟喹诺酮类、硝基呋喃类、磺胺类和四环素类大多在当地生产,而头孢菌素类、大环内酯类和“其他”类抗菌药物则为进口。氯霉素类和青霉素类完全依赖进口,硝基呋喃类仅在当地生产。总体而言,除四环素类外,2020年当地生产和/或进口的抗菌药物数量低于2018年,这与可获得的抗菌药物总量呈下降趋势一致。此外,随后几年中,至关重要的抗生素使用量有所下降,尤其是I类抗生素。最后,本研究首次为尼泊尔未来监测食用动物抗菌药物使用情况建立了一个基准。这些数据对于风险分析、规划、解读耐药性监测数据以及评估谨慎使用措施、努力和缓解策略的有效性很有用。